Women's Health
FDA Office of Women's Health (OWH)
OWH protects and promotes the health of women through policy, science, education, and outreach.
Featured
National Women's Health Week (NWHW) 2024
This year, NWHW is observed May 12–18, 2024. NWHW is a reminder for women of all ages to prioritize their health. FDA OWH’s NWHW 2024 theme is "Know Your Bones" to empower women to take charge of their bone health.
Osteoporosis: A Perspective for 2024
Join OWH for a webinar on May 16 at 12PM. This lecture will summarize the current approach to assessing bone health, as well as preventing and treating osteoporosis with a focus on postmenopausal women. Offering CE credits. Register to attend.
Spolight on Syphilis and Congenital Syphilis
Learn more about syphilis and congenital syphilis—sexually transmitted infections that can cause serious health problems if left untreated.
Understanding Pregnancy Exposure Registries
Are you pregnant and taking medicines or received a vaccine? You can help pregnant patients and health care providers understand the effects of medicines and vaccines used during pregnancy by volunteering to enroll in a pregnancy exposure registry study.
Menopause: Potential Impact on Clinical Pharmacology
OWH and CDER/OCP hosted a virtual public workshop to discuss the physiologic changes that occur during menopause and the potential effects of menopause on the pharmacokinetics and pharmacodynamics of drugs.
Women's Health Research
We promote and conduct research initiatives that advance understanding of sex differences and health conditions unique to women.
Paragraph Header
Contact Us
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993